메뉴 건너뛰기




Volumn 40, Issue 6 II, 1999, Pages

Pharmacokinetics of fluconazole in skin and nails

Author keywords

[No Author keywords available]

Indexed keywords

FLUCONAZOLE; GRISEOFULVIN; ITRACONAZOLE; KETOCONAZOLE; TERBINAFINE;

EID: 0033059159     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0190-9622(99)70393-2     Document Type: Conference Paper
Times cited : (24)

References (21)
  • 1
    • 0015399523 scopus 로고
    • Griseofulvin levels in stratum corneum: study after oral administration in man
    • WL Epstein WOP Shah S. Riegelman Griseofulvin levels in stratum corneum: study after oral administration in man Arch Dermatol 106 1972 344 348
    • (1972) Arch Dermatol , vol.106 , pp. 344-348
    • Epstein, WL1    Shah, WOP2    Riegelman, S.3
  • 2
    • 0021045462 scopus 로고
    • Orally administrated ketoconazole: route of delivery to the human stratum corneum
    • R Harris HE Jones WM. Artis Orally administrated ketoconazole: route of delivery to the human stratum corneum Antimicrob Agents Chemother 24 1983 876 882
    • (1983) Antimicrob Agents Chemother , vol.24 , pp. 876-882
    • Harris, R1    Jones, HE2    Artis, WM.3
  • 6
    • 0027328120 scopus 로고
    • Levels of terbinafine in plasma, stratum corneum, dermis-epidermis (without stratum corneum), sebum, hair and nails during and after 250 mg terbinafine orally once per day for four weeks
    • J Faergemann H Zehender J Denouël L Millerioux Levels of terbinafine in plasma, stratum corneum, dermis-epidermis (without stratum corneum), sebum, hair and nails during and after 250 mg terbinafine orally once per day for four weeks Acta Derm Venereol (Stockh) 73 1993 305 309
    • (1993) Acta Derm Venereol (Stockh) , vol.73 , pp. 305-309
    • Faergemann, J1    Zehender, H2    Denouël, J3    Millerioux, L4
  • 7
    • 0028283024 scopus 로고
    • Levels of terbinafine in plasma, stratum corneum, dermis-epidermis (without stratum corneum), sebum, hair and nails during and after 250 mg terbinafine orally once daily for 7 and 14 days
    • J Faergemann H Zehender L. Millerioux Levels of terbinafine in plasma, stratum corneum, dermis-epidermis (without stratum corneum), sebum, hair and nails during and after 250 mg terbinafine orally once daily for 7 and 14 days Clin Exp Dermatol 19 1994 121 126
    • (1994) Clin Exp Dermatol , vol.19 , pp. 121-126
    • Faergemann, J1    Zehender, H2    Millerioux, L.3
  • 8
    • 0031034283 scopus 로고    scopus 로고
    • A double-blind comparison of levels of terbinafine and itraconazole in plasma, skin, sebum, hair and nails during and after oral medication
    • J Faergemann H Zehender A Boukhabza SG Smith TC. Jones A double-blind comparison of levels of terbinafine and itraconazole in plasma, skin, sebum, hair and nails during and after oral medication Acta Derm Venereol (Stockh) 77 1997 74 76
    • (1997) Acta Derm Venereol (Stockh) , vol.77 , pp. 74-76
    • Faergemann, J1    Zehender, H2    Boukhabza, A3    Smith, SG4    Jones, TC.5
  • 9
    • 0027532417 scopus 로고
    • Levels of fluconazole in serum, stratum corneum, epidermis-dermis (without stratum corneum) and eccrine sweat
    • J Faergemann H. Laufen Levels of fluconazole in serum, stratum corneum, epidermis-dermis (without stratum corneum) and eccrine sweat Clin Exp Dermatol 18 1993 102 106
    • (1993) Clin Exp Dermatol , vol.18 , pp. 102-106
    • Faergemann, J1    Laufen, H.2
  • 10
    • 0029890133 scopus 로고    scopus 로고
    • Levels of fluconazole in normal and diseased nails during and after treatment of onychomycoses in toe-nails with fluconazole 150 mg once daily
    • J Faergemann H. Laufen Levels of fluconazole in normal and diseased nails during and after treatment of onychomycoses in toe-nails with fluconazole 150 mg once daily Acta Derm Venereol (Stockh) 76 1996 219 221
    • (1996) Acta Derm Venereol (Stockh) , vol.76 , pp. 219-221
    • Faergemann, J1    Laufen, H.2
  • 11
    • 0028871489 scopus 로고
    • Intracutaneous transport of orally administered fluconazole to the stratum corneum
    • J Faergemann J Goodleski H Laufen RH. Liss Intracutaneous transport of orally administered fluconazole to the stratum corneum Acta Derm Venereol (Stockh) 75 1995 361 363
    • (1995) Acta Derm Venereol (Stockh) , vol.75 , pp. 361-363
    • Faergemann, J1    Goodleski, J2    Laufen, H3    Liss, RH.4
  • 12
    • 0025363182 scopus 로고
    • Fluconazole: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in superficial and systemic mycoses
    • SM Grant SP. Clissold Fluconazole: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in superficial and systemic mycoses Drugs 39 1990 877 916
    • (1990) Drugs , vol.39 , pp. 877-916
    • Grant, SM1    Clissold, SP.2
  • 13
    • 85119801790 scopus 로고
    • Fluconazole: a novel advance in therapy for systemic fungal infections. Proc Rev Infect Dis 12 suppl 1990 S263 S389 Dorado Beach, Puerto Rico, 8-9 October 1988
    • (1990) Proc Rev Infect Dis , vol.12 , Issue.suppl , pp. S263-S389
  • 14
    • 0026496640 scopus 로고
    • Pharmacokinetic evaluation of fluconazole in plasma, epidermis and blister fluid
    • E. Haneke Pharmacokinetic evaluation of fluconazole in plasma, epidermis and blister fluid Int J Dermatol 31 suppl 1992 3 5
    • (1992) Int J Dermatol , vol.31 , Issue.suppl , pp. 3-5
    • Haneke, E.1
  • 15
    • 0026469938 scopus 로고
    • Pharmacokinetic evaluation of fluconazole in skin and nails
    • RJ. Hay Pharmacokinetic evaluation of fluconazole in skin and nails Int J Dermatol 31 suppl 1992 6 7
    • (1992) Int J Dermatol , vol.31 , Issue.suppl , pp. 6-7
    • Hay, RJ.1
  • 16
    • 85037386296 scopus 로고    scopus 로고
    • Distribution of fluconazole in dermal tissues on various treatment schedules
    • H Laufen T Zimmermann A Wildfeuer RA. Yeates Distribution of fluconazole in dermal tissues on various treatment schedules Presented at Clinical Dermatology 2000, Vancouver, Canada May 28-31, 1996
    • (1996)
    • Laufen, H1    Zimmermann, T2    Wildfeuer, A3    Yeates, RA.4
  • 17
    • 0030931282 scopus 로고    scopus 로고
    • A multicentre (double-blind) comparative study to assess the safety and efficacy of fluconazole and griseofulvin in the treatment of tinea corporis and tinea cruris
    • J Faergemann NJ Mörk A Haglund T Ödegfård A multicentre (double-blind) comparative study to assess the safety and efficacy of fluconazole and griseofulvin in the treatment of tinea corporis and tinea cruris Br J Dermatol 136 1997 575 577
    • (1997) Br J Dermatol , vol.136 , pp. 575-577
    • Faergemann, J1    Mörk, NJ2    Haglund, A3    Ödegfård, T4
  • 18
    • 0026489373 scopus 로고
    • Once-weekly oral doses of fluconazole 150 mg in the treatment of tinea corporis/cruris and cutaneous candidiasis
    • P Suchil FM Gei M Robles A Perera-Ramirez O Welsh O. Male Once-weekly oral doses of fluconazole 150 mg in the treatment of tinea corporis/cruris and cutaneous candidiasis Clin Exp Dermatol 17 1992 397 401
    • (1992) Clin Exp Dermatol , vol.17 , pp. 397-401
    • Suchil, P1    Gei, FM2    Robles, M3    Perera-Ramirez, A4    Welsh, O5    Male, O.6
  • 19
    • 0026482999 scopus 로고
    • Once-weekly oral doses of fluconazole 150 mg in the treatment of tinea pedis
    • R Del Aguila FM Gei M Robles A Perera-Ramirez O. Male Once-weekly oral doses of fluconazole 150 mg in the treatment of tinea pedis Clin Exp Dermatol 17 1992 402 406
    • (1992) Clin Exp Dermatol , vol.17 , pp. 402-406
    • Del Aguila, R1    Gei, FM2    Robles, M3    Perera-Ramirez, A4    Male, O.5
  • 20
    • 0026726520 scopus 로고
    • Fluconazole in the treatment of onychomycosis caused by dermatophytes
    • K Kuokkanen S. Alava Fluconazole in the treatment of onychomycosis caused by dermatophytes J Dermatol Treat 3 1992 115 117
    • (1992) J Dermatol Treat , vol.3 , pp. 115-117
    • Kuokkanen, K1    Alava, S.2
  • 21
    • 0029764758 scopus 로고    scopus 로고
    • Fluconazole in the treatment of severe onychomycosis
    • F. Montero-Gei Fluconazole in the treatment of severe onychomycosis Int J Dermatol 35 1996 587 588
    • (1996) Int J Dermatol , vol.35 , pp. 587-588
    • Montero-Gei, F.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.